CDC Announces Shortage of Nirsevimab, Used for RSV : vimarsa

Nirsevimab, a monoclonal antibody used to protect infants from respiratory syncytial virus (RSV), is in limited supply, according to a CDC announcement.

Related Keywords

Alaska , United States , American , , Advisory Committee On Immunization Practices , American Academy Of Pediatrics , Immunization Practices , American Indian , Alaska Native , American Academy , Nirsevimab , Cdc , Rsv , Infants , Monoclonal Antibody ,